RAMESH KUMAR, Ph.D.
PRESIDENT AND CEO
Dr. Kumar is a co-founder of Onconova. He received his Ph.D. in Molecular Biology from the University of Illinois, Chicago, and trained at the National Cancer Institute. He has held positions in R&D or management at Princeton University, Bristol-Myers Squibb, DNX (later Nextran, a subsidiary of Baxter) and Kimeragen (later Valigen), where he was President of the Genomics and Transgenics Division. Dr. Kumar has more than 50 publications spanning the areas of molecular oncology, transgenic animals, gene therapy and recombination. He is an inventor in 8 U.S. patents and many patent applications. He co-edited the 1993 book "Molecular Basis of Human Cancer".
rkumar@onconova.us
JAMES R. ALTLAND
SENIOR VP FINANCE &
CORPORATE DEVELOPMENT
Mr. Altland is a CPA in Ohio and is a graduate of the University of Akron. He was a Partner of Tatum LLC where, as the Senior Partner in the Philadelphia office, he was Practice Leader for the life science segment. Mr. Altland served as CFO at LifeTime Pharmaceuticals and NorthStar Research & Development, Ltd. He is the former President and CEO of JRA Consulting, where he provided consulting services to early stage life science and technology companies. During his earlier years he held various management positions with Dietrich's Milk Products, IFR Furniture Rentals, IC Industries/Whitman's Chocolates, Tasty Baking Co. and The JM Smucker Company.
jaltland@onconova.us
MANOJ MANIAR, Ph.D.
SENIOR VICE PRESIDENT,
PRODUCT DEVELOPMENT
Dr. Maniar received his B.S. in Pharmacy from Bombay College and his Ph.D. in Pharmaceutics from the University of Connecticut. He has led the development and commercialization of several pharmaceutical products and medical devices during his career. Prior to joining Onconova, Dr. Maniar was with SRI International, where he served as Senior Director, Formulations and Drug Delivery. He has authored more than 100 patents, publications, and presentations in the field of pharmaceutical sciences.
mmaniar@onconova.us
FRANCOIS E. WILHELM, M.D., Ph.D.
CHIEF MEDICAL OFFICER AND
SENIOR VICE PRESIDENT
Dr. Wilhelm is Board Certified in Rheumatology, receiving his medical degree from Paris University Medical School, his Ph.D. in Endocrinology and a Master's degree in Biostatistic, both from the University of Paris. He has 23 years of clinical development experience covering all phases of drug development and post-marketing in Europe (Hoffmann-La Roche) and in the U.S. (Fujisawa, Pfizer, Procter & Gamble, Akros Pharma, Johnson and Johnson). He has been involved in clinical development programs in oncology-hematology, immunology, inflammation, virology, bone metabolism, endocrinology, women's health, coagulation and lipid metabolism. He has authored more than 30 publications.
fwilhelm@onconova.us
STANLEY C. BELL, Ph.D
1931-2009
Visit the Stanley C. Bell memorial page
